| | | | | |
| €27,2943 | -0,02% | €240,42M | €1,16K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0508 | +0,00% | €240,13M | €40,06K | |
TSI TCW Strategic Income Fund, Inc. | €3,7541 | +0,00% | €239,73M | €219,19K | |
PAII Pyrophyte Acquisition Corp. II | €8,7981 | -0,05% | €239,31M | €15,52K | |
| €12,0251 | +0,21% | €239,19M | €861,38 | |
YDES YD Bio Limited Ordinary Shares | €3,9855 | -0,22% | €239,19M | €3,428 | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,5624 | +0,00% | €238,88M | €23,99 | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6311 | +0,00% | €238,87M | €331,90K | |
JILL J.Jill, Inc. Common Stock | €17,1506 | +0,00% | €238,86M | €29,68K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,88281 | -5,50% | €238,44M | €215,98 | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8410 | -0,05% | €238,37M | €12,54K | |
ACV Virtus Diversified Income & Convertible Fund | €22,6789 | +0,00% | €238,35M | €8,42K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7013 | -0,25% | €238,21M | €208,47K | |
| €1,1999 | +0,00% | €238,13M | €0,8571 | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5713 | +0,00% | €237,98M | €43,03K | |
